Poster zum Thema "Immunopeptidomics"

Zurück
  • P-III-1084
Combining FAIMS-DIA and targeted immunopeptidomics to enhance neoepitope discovery
  • Jonas P. Becker (Heidelberg / DE)
  • P-III-1085
An optimized mild acid elution (MAE) sample preparation workflow enabling MS-based immunopeptidome analysis from less than 1x106 cells
  • P-III-1086
Impact of dipeptidyl peptidase 9 on the MHC class I immunopeptidome
  • P-III-1087
Integrating immunopeptidomics and RNA sequencing for neoantigen discovery in NSCLC
  • P-III-1088
Benchmarking of high-throughput immunopeptidomics workflows
  • P-III-1089
Thunder-DDA-PASEF enables the identification of mRNA splicing-derived immunopeptides in human tumor cell lines
  • P-III-1090
Kinetics of HLA antigen presentation in transition from latent to Lytic stage of EBV
  • P-III-1091
Neoantigen discovery in renal cell carcinoma through comparative immunopeptidome profiling of RENCA xenograft models
  • P-III-1092
Screening covalent small molecules that modulate HLA-I and HLA-II expression and their effect on the HLA immunopeptidome repertoire
  • P-III-1093
Immunopeptidomics for the identification of microbiota-derived antigens in colorectal cancer
  • P-III-1094
MSRescue improves De Novo candidate selection
  • P-III-1095
Dia-PASEF for in-depth immunopeptidomics analysis: challenges and new opportunities
  • P-III-1096
Characterization of bioactive peptides from Tuna waste fermentation by Lactobacillus plantarum and Bacillus subtilis using mass spectrometric analysis
  • P-III-1097
Sensitive and high-throughput immunopeptidomics using the latest generation Orbitrap astral and ascend
  • P-III-1098
Deciphering the MHC-I/II Immunopeptidome landscape of murine tumor with normal tissues for neoantigen discovery
  • P-III-1099
High sensitivity combined proteomic and immunopeptidomic analysis of synovial tissue of rheumatoid arthritis patients
  • P-III-1100
Fine tuning of ddaPASEF methods improves the immunopeptidomics coverage and throughput, which is further boosted by ML-assisted rescoring
  • P-III-1101
Enhancing immunopeptide profiling with Orbitrap astral mass spectrometer for unbiased discovery of neoantigens
  • P-III-1102
The SysteMHC Atlas v2.5
  • P-III-1103
Venturing into the unknown: non-canonical antigen discovery
  • P-III-1104
Personalized de novo peptide sequencing to identify non-canonical HLA peptides from individual-patient immunopeptidome
  • P-III-1105
Unipept next: next-generation peptide analysis tool for HLA-peptide identification
  • P-III-1106
Plasma immunopeptidomic landscape in patients with alpha-1 antitrypsin deficiency
  • P-III-1107
Maximizing immunopeptide identification and reproducibility from minute pediatric solid tumor biopsy samples
  • P-III-1108
Overcoming low tumor mutational burden in cancer antigen discovery
    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH